About the Authors
- Mahamadou A. Thera
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Ogobara K. Doumbo
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Drissa Coulibaly
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Matthew B. Laurens
-
Affiliation Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Abdoulaye K. Kone
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Ando B. Guindo
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Karim Traore
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Mady Sissoko
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Dapa A. Diallo
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Issa Diarra
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Bourema Kouriba
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Modibo Daou
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Amagana Dolo
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Mounirou Baby
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Mahamadou S. Sissoko
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Issaka Sagara
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Amadou Niangaly
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Idrissa Traore
-
Affiliation Malaria Research and Training Center, University of Bamako, Bamako, Mali
- Ally Olotu
-
Current address: KEMRI-Wellcome Trust Research Programme, Kilifi, Kenya
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
- Olivier Godeaux
-
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
- Amanda Leach
-
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
- Marie-Claude Dubois
-
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
- W. Ripley Ballou
-
Current address: Bill and Melinda Gates Foundation, Seattle, Washington, United States of America
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
- Joe Cohen
-
Affiliation GlaxoSmithKline Biologicals, Rixensart, Belgium
- Darby Thompson
-
Affiliation EMMES Corporation, Rockville, Maryland, United States of America
- Tina Dube
-
Affiliation EMMES Corporation, Rockville, Maryland, United States of America
- Lorraine Soisson
-
Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D.C., United States of America
- Carter L. Diggs
-
Affiliation Malaria Vaccine Development Program, U.S. Agency for International Development, Washington, D.C., United States of America
- Shannon L. Takala
-
Affiliation Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Kirsten E. Lyke
-
Affiliation Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
- Brent House
-
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- David E. Lanar
-
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- Sheetij Dutta
-
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- D. Gray Heppner
-
Affiliation Division of Malaria Vaccine Development, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America
- Christopher V. Plowe
-
* E-mail: cplowe@medicine.umaryland.edu
Affiliation Howard Hughes Medical Institute/Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America
Competing Interests
SD and DEL hold patents for the FMP2.1 vaccine antigen. OG, AL, WRB, MCD and JC are or were employees of GlaxoSmithKline Biologicals, the manufacturer of the proprietary Adjuvant System AS02A, and hold shares in GlaxoSmithKline. None of the other authors have declared conflict of interest.
Author Contributions
Conceived and designed the experiments: MAT OKD DC AKK ABG KT DAD AD MSS IS AN AO OG AL MCD WRB JC LS CD KEL DGH CVP. Performed the experiments: MAT OKD DC MBL AKK ABG KT MS DAD ID BK MD AD MB MSS IS AN IT KEL BH CVP. Analyzed the data: MAT MBL MSS IS DT TJD SLT KEL BH CVP. Contributed reagents/materials/analysis tools: AO OG AL MCD WRB JC DL SD DGH. Wrote the paper: MAT MBL OG MCD JC LS CD SLT KEL DGH CVP.